[
    [
        {
            "time": "",
            "orginal_text": "被高瓴看好医药外包行业 具备诞生世界龙头的潜力（附股）",
            "features": {
                "keywords": [
                    "高瓴",
                    "医药外包",
                    "世界龙头",
                    "潜力"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "外包行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "被高瓴看好医药外包行业 具备诞生世界龙头的潜力（附股）",
            "scores": {
                "News_content": "被高瓴看好医药外包行业 具备诞生世界龙头的潜力（附股）",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "国际药企受疫情影响暂缓研发计划 国内CRO公司复工复产或迎发展良机",
            "features": {
                "keywords": [
                    "疫情",
                    "国际药企",
                    "研发计划",
                    "CRO公司",
                    "复工复产",
                    "发展良机"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "CRO公司"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "国际药企受疫情影响暂缓研发计划 国内CRO公司复工复产或迎发展良机",
            "scores": {
                "News_content": "国际药企受疫情影响暂缓研发计划 国内CRO公司复工复产或迎发展良机",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "【粤开策略】两股连续十日获外资增持",
            "features": {
                "keywords": [
                    "粤开策略",
                    "外资",
                    "增持"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【粤开策略】两股连续十日获外资增持",
            "scores": {
                "News_content": "【粤开策略】两股连续十日获外资增持",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "QFII一季度青睐白马股，重仓银行医药电子",
            "features": {
                "keywords": [
                    "QFII",
                    "一季度",
                    "白马股",
                    "重仓",
                    "银行",
                    "医药",
                    "电子"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "银行",
                    "医药",
                    "电子"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "QFII一季度青睐白马股，重仓银行医药电子",
            "scores": {
                "News_content": "QFII一季度青睐白马股，重仓银行医药电子",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "三维工程“双方案”8.48亿元收购诺奥化工 盈科资本参与战略投资",
            "features": {
                "keywords": [
                    "三维工程",
                    "双方案",
                    "收购",
                    "诺奥化工",
                    "盈科资本",
                    "战略投资"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化工"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "三维工程“双方案”8.48亿元收购诺奥化工 盈科资本参与战略投资",
            "scores": {
                "News_content": "三维工程“双方案”8.48亿元收购诺奥化工 盈科资本参与战略投资",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "【光大医药|Q1点评】泰格医药：业绩仍实现增长，H股上市有望加速国际化",
            "features": {
                "keywords": [
                    "光大医药",
                    "Q1点评",
                    "泰格医药",
                    "业绩增长",
                    "H股上市",
                    "国际化"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【光大医药|Q1点评】泰格医药：业绩仍实现增长，H股上市有望加速国际化",
            "scores": {
                "News_content": "【光大医药|Q1点评】泰格医药：业绩仍实现增长，H股上市有望加速国际化",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]